Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inflammation-associated drug resistance and tumor growth in TNBC

26 Aug 2025

Abstract excerpt

Triple-negative breast cancer (TNBC) is an aggressive and clinically challenging subtype of breast cancer characterized by the absence of hormone receptors and HER2 amplification. This molecular profile limits the effectiveness of targeted therapies, leaving chemotherapy as the mainstay of treatment a strategy often met with limited success due to rapid disease progression and high recurrence rates. Increasing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune cells in cancer
Share to Inflammatory Biomarkers in Disease Prognosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40933989
DOI: 10.3389/fimmu.2025.1623137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inflammation-associated drug resistance and tumor growth in TNBCPMID 40933989Read ↗

Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugsSemantic proximity Read ↗

Interleukin-17-based cytokine signaling as a determinant for tumor immune microenvironment with prognostic value in triple-negative breast cancerSemantic proximity Read ↗

TNFRSF12A Drives Triple-Negative Breast Cancer Progression via Immune Microenvironment Reprogramming and Facilitated AngiogenesisSemantic proximity Read ↗

Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancerSemantic proximity Read ↗

The IL-8/NF-κB feedback loop confers a paclitaxel-sensitive/doxorubicin-resistant phenotype in triple-negative breast cancerSemantic proximity Read ↗

Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.Semantic proximity Read ↗

Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.Semantic proximity Read ↗

Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment ApproachSemantic proximity Read ↗

Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and anti-tumoral activity upon IL-10 or TGFβ stimulationSemantic proximity Read ↗

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read ↗

Immune Landscape of Breast CancersSemantic proximity Read ↗

Targeting an IKBKE cytokine network impairs triple-negative breast cancer growthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.